Skip to main content
M

medara

medara provides an AI platform that analyzes longitudinal imaging and clinical data to generate personalized disease risk assessments, helping radiologists prioritize high‑risk patients for early cancer detection. The system integrates directly with existing PACS workflows, automatically delivering patient‑specific risk scores at the point of image review to support timely intervention and reduce screening costs. By combining imaging and clinical information, medara enables more precise, data‑driven screening protocols.

New York, United StatesFounded 202561K+ followers
Updated 29 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Radiologists often lack tools to efficiently assess an individual’s future cancer risk from existing imaging and clinical records, leading to generic screening schedules, delayed detection, and unnecessary procedures.

Solution

Medara applies artificial intelligence to longitudinal imaging and associated clinical data to generate personalized cancer risk scores for each patient. The AI engine integrates directly with PACS, automatically analyzing new image sets as they are archived and combining them with historical clinical information. Risk assessments are presented within the radiologist’s workflow, highlighting high‑risk cases for expedited review and follow‑up imaging. By tailoring screening intervals and modality choices to the predicted risk, clinicians can intervene earlier for those most likely to develop cancer while avoiding over‑screening low‑risk patients. This approach aims to improve detection rates, reduce unnecessary procedures, and lower overall healthcare costs.

Target Audience

Primary users are radiologists and imaging departments in hospitals and diagnostic centers that manage large volumes of longitudinal imaging studies and aim to optimize cancer screening protocols.

Features

  • AI-driven analysis of serial imaging studies combined with patient clinical data to produce individualized cancer risk scores
  • Seamless PACS integration that triggers risk assessment automatically upon image acquisition
  • Real‑time risk score display within the radiology viewer, enabling case prioritization for urgent review
  • Decision support recommendations for screening intervals and imaging modality selection based on predicted risk
  • Continuous learning model that updates risk predictions as new imaging and clinical information become available
This profile is AI-generated and may contain inaccuracies.